
October 7, 2025 – The ATA announces with pleasure that M. Regina Castro, MD, a…
October 7, 2025 – The ATA announces with pleasure that M. Regina Castro, MD, a…
Drs Kaniksha Desai and Julie Ann Sosa discuss the 2025 American Thyroid Association guidelines for…
From Medscape® Diabetes & Endocrinology Coverage from the American Thyroid Association® (ATA) 2025 Meeting Can…
Hypothyroidism is a common endocrine problem affecting mostly women. If untreated, it leads to impaired quality of life and function. The standard therapy for hypothyroidism, as recommended by the American Thyroid Association® (ATA), is synthetic levothyroxine, a safe and effective therapy. The US Food and Drug Administration (FDA) regulates levothyroxine medications to ensure bioavailability, dose equivalence, potency, and purity.
September 11, 2025 – The American Thyroid Association® is delighted to recognize W. Edward Visser,…
ATA recognized 12 outstanding abstracts presented at the 17th ITC meeting held in Rio de…